• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和评估两种潜在的 5-HT 受体 PET 示踪剂:[F]ENL09 和 [F]ENL10。

Development and Evaluation of Two Potential 5-HT Receptor PET Tracers: [F]ENL09 and [F]ENL10.

机构信息

Neurobiology Research Unit , Rigshospitalet, Blegdamsvej 9 , 2100 Copenhagen , Denmark.

Department for Drug Design and Pharmacology, Faculty of Health and Medical Sciences , University of Copenhagen , Universitetsparken 2 , 2100 Copenhagen , Denmark.

出版信息

ACS Chem Neurosci. 2019 Sep 18;10(9):3961-3968. doi: 10.1021/acschemneuro.9b00132. Epub 2019 Apr 22.

DOI:10.1021/acschemneuro.9b00132
PMID:30973705
Abstract

The latest addition to the serotonin (5-HT) receptor family is the 5-HT receptor (5-HTR). This receptor has gained interest as a drug target due to its involvement in various disorders such as depression or schizophrenia. There is currently no clinically validated positron emission tomography (PET) tracer for the 5-HTR available. But, the (arylpiperazinyl-butyl)oxindole scaffold provides a promising lead structure for this purpose. Here, we synthesized 12 (arylpiperazinyl-butyl)oxindole derivatives and in vitro affinity screening identified two structures with suitable affinity and selectivity to be radiolabeled and tested as 5-HTR selective PET tracers. Next, the radiolabeled products [F]ENL09 and [F]ENL10 were evaluated as PET tracers in rats. Both tracers were found to be P-gp substrates, but after P-gp inhibition the brain uptake showed a regional distribution in line with the known 5-HTR distribution.  The [F]ENL10 brain binding was displaceable with a 5-HTR selective ligand, whereas [F]ENL09 was not. We find that [F]ENL10 is a promising 5-HTR selective PET tracer candidate that should be investigated in higher species.

摘要

血清素(5-HT)受体家族的最新成员是 5-HT 受体(5-HTR)。由于其与抑郁症或精神分裂症等各种疾病有关,该受体已成为药物靶点的研究热点。目前,尚无临床验证的 5-HTR 正电子发射断层扫描(PET)示踪剂可用。但是,(芳基哌嗪基-丁基)吲哚酮支架为此提供了有希望的先导结构。在这里,我们合成了 12 种(芳基哌嗪基-丁基)吲哚酮衍生物,并通过体外亲和筛选鉴定了两种具有合适亲和力和选择性的结构,可被放射性标记并用作 5-HTR 选择性 PET 示踪剂进行测试。接下来,放射性标记产物 [F]ENL09 和 [F]ENL10 被评估为大鼠中的 PET 示踪剂。两种示踪剂均被发现是 P-糖蛋白(P-gp)的底物,但在 P-gp 抑制后,脑摄取显示出与已知 5-HTR 分布一致的区域分布。[F]ENL10 的脑结合可被 5-HTR 选择性配体置换,而 [F]ENL09 则不能。我们发现 [F]ENL10 是一种很有前途的 5-HTR 选择性 PET 示踪剂候选物,应在更高种属中进行研究。

相似文献

1
Development and Evaluation of Two Potential 5-HT Receptor PET Tracers: [F]ENL09 and [F]ENL10.开发和评估两种潜在的 5-HT 受体 PET 示踪剂:[F]ENL09 和 [F]ENL10。
ACS Chem Neurosci. 2019 Sep 18;10(9):3961-3968. doi: 10.1021/acschemneuro.9b00132. Epub 2019 Apr 22.
2
Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.新型放射性配体用于 PET 成像脑 5-HT7 受体的放射合成及体内评价。
J Nucl Med. 2014 Apr;55(4):640-6. doi: 10.2967/jnumed.113.128983. Epub 2014 Feb 24.
3
Comparison of 4 radiolabeled antagonists for serotonin 5-HT(7) receptor neuroimaging: toward the first PET radiotracer.4 种放射性标记的 5-羟色胺 5-HT(7) 受体拮抗剂的比较:迈向首个 PET 放射性示踪剂。
J Nucl Med. 2011 Nov;52(11):1811-8. doi: 10.2967/jnumed.111.089185. Epub 2011 Oct 11.
4
Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.18F-F13714 作为氟代 5-HT1A 受体激动剂放射性配体用于 PET 神经影像学的放射性合成和临床前评价。
J Nucl Med. 2012 Jun;53(6):969-76. doi: 10.2967/jnumed.111.101212. Epub 2012 May 10.
5
Synthesis and biological evaluation of potential 5-HT(7) receptor PET radiotracers.潜在 5-HT(7) 受体 PET 放射性示踪剂的合成与生物学评价。
Eur J Med Chem. 2011 Aug;46(8):3455-61. doi: 10.1016/j.ejmech.2011.05.010. Epub 2011 May 12.
6
Evaluation of [ F]2FP3 in pigs and non-human primates.[F]2FP3在猪和非人灵长类动物中的评估。
J Labelled Comp Radiopharm. 2019 Jan;62(1):34-42. doi: 10.1002/jlcr.3692. Epub 2018 Dec 6.
7
Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging.氟[18F]2FNQ1P 作为用于 PET 成像的首个氟代血清素 5-HT6 放射性配体的临床前评价。
Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):495-502. doi: 10.1007/s00259-014-2936-y. Epub 2014 Oct 21.
8
Preclinical validation of [F]2FNQ1P as a specific PET radiotracer of 5-HT receptors in rat, pig, non-human primate and human brain tissue.在大鼠、猪、非人灵长类动物和人脑组织中,对[F]2FNQ1P 作为 5-HT 受体特异性 PET 放射性示踪剂进行临床前验证。
Nucl Med Biol. 2020 Mar-Apr;82-83:57-63. doi: 10.1016/j.nucmedbio.2020.01.006. Epub 2020 Jan 22.
9
Radiosynthesis and preclinical evaluation of [ C]Cimbi-701 - Towards the imaging of cerebral 5-HT receptors.[ C]Cimbi-701 的放射性合成与临床前评估 - 迈向大脑 5-HT 受体成像。
J Labelled Comp Radiopharm. 2020 Feb;63(2):46-55. doi: 10.1002/jlcr.3808. Epub 2020 Jan 6.
10
Synthesis and evaluation of 1-[2-(4-[(11)C]methoxyphenyl)phenyl]piperazine for imaging of the serotonin 5-HT7 receptor in the rat brain.合成及评价 1-[2-(4-[(11)C]甲氧基苯基)苯基]哌嗪作为大鼠脑内 5-羟色胺 5-HT7 受体显像剂
Bioorg Med Chem. 2013 Sep 1;21(17):5316-22. doi: 10.1016/j.bmc.2013.06.020. Epub 2013 Jun 17.

引用本文的文献

1
Tc(CO)-labeled 1-(2-Pyridyl)piperazine derivatives as radioligands for 5-HT receptors.Tc(CO)-标记的 1-(2-吡啶基)哌嗪衍生物作为 5-HT 受体的放射性配体。
Ann Nucl Med. 2024 Feb;38(2):139-153. doi: 10.1007/s12149-023-01885-2. Epub 2023 Nov 30.
2
Radiotracers for the Central Serotoninergic System.中枢5-羟色胺能系统的放射性示踪剂
Pharmaceuticals (Basel). 2022 May 3;15(5):571. doi: 10.3390/ph15050571.
3
Radionuclide Imaging for Neuroscience: Current Opinion and Future Directions.神经科学的放射性核素成像:当前观点与未来方向
Mol Imaging. 2020 Jan-Dec;19:1536012120936397. doi: 10.1177/1536012120936397.